Literature DB >> 9801205

Cytologic analysis of papillary renal cell carcinoma.

S R Granter1, A R Perez-Atayde, A A Renshaw.   

Abstract

BACKGROUND: The papillary variant of renal cell carcinoma has distinctive pathologic and clinical features. Because the prognosis of patients with papillary renal cell carcinoma differs from that of patients with other variants of renal cell carcinoma, accurate diagnosis based on cytologic material may be important for appropriate clinical disease management.
METHODS: A retrospective analysis of cytologic material from 17 papillary renal cell carcinomas and 52 other renal neoplasms with histologic follow-up was performed to identify the relative sensitivity and specificity of different cytologic criteria for papillary carcinoma.
RESULTS: Foamy macrophages and intracytoplasmic hemosiderin were the most sensitive and most specific criteria for the diagnosis of papillary renal cell carcinoma. Foamy macrophages were present in 14 of 17 cases (82%), and intracytoplasmic hemosiderin was present in 13 of 17 cases (76%). Foamy macrophages and intracellular hemosiderin were each present in only 2 of 52 (4%) of nonpapillary tumors examined. Malignant cells were arranged in papillary groups with fibrovascular cores in only 6 of 17 cases (35%), including only 1 of 7 high grade tumors. Nuclear grooves were present in 9 of 17 cases (53%) but were common in only 2 cases. Psammoma bodies were present in only 1 case. Nucleoli and pleomorphism were prominent in high grade tumors. These features, in association with frequent abundant vacuolated cytoplasm, made it difficult to distinguish high grade papillary carcinoma from the clear cell variant of renal cell carcinoma. However, as with low grade tumors, the presence of intracytoplasmic hemosiderin and foamy macrophages were important clues to the diagnosis of 6 of 7 high grade tumors (86%).
CONCLUSIONS: Intracytoplasmic hemosiderin and foamy macrophages are the most sensitive and specific markers for both high and low grade papillary renal cell carcinoma, and they allow for the correct diagnosis in most cases.

Entities:  

Mesh:

Year:  1998        PMID: 9801205     DOI: 10.1002/(sici)1097-0142(19981025)84:5<303::aid-cncr6>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Intranuclear Inclusions in Conventional Clear Cell Renal Cell Carcinoma (ccRCC): Diagnosis and Differential Diagnosis.

Authors:  Aryn McClain; Lynne Sakowski; Michele Conti; Hui Zhang; Qing Kay Li
Journal:  Arch Urol Res       Date:  2018-10-24

2.  Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.

Authors:  Margareta Strojan Fležar; Helena Gutnik; Jera Jeruc; Irena Srebotnik Kirbiš
Journal:  Virchows Arch       Date:  2011-11-04       Impact factor: 4.064

Review 3.  Risk factors, classification, and staging of renal cell cancer.

Authors:  Damian A Laber
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

4.  Mixed epithelial and stromal tumor of the kidney composed mainly of solid components: A case report.

Authors:  Kiyoka Maeba; Akihiko Kanki; Hiroyuki Watanabe; Akira Yamamoto; Yasuto Fujimoto; Miyaji Yoshiyuki; Tsutomu Tamada
Journal:  Acta Radiol Open       Date:  2022-07-01

5.  Cytologic features of metanephric adenoma of the kidney.

Authors:  José A Jiménez-Heffernan; Eva Tejerina; Pilar González-Peramato; Blanca Vicandi; Ana López-García
Journal:  Cytojournal       Date:  2009-04-04       Impact factor: 2.091

6.  Iron accumulation typifies renal cell carcinoma tumorigenesis but abates with pathological progression, sarcomatoid dedifferentiation, and metastasis.

Authors:  Christopher J Greene; Kristopher Attwood; Nitika J Sharma; Benjamin Balderman; Rongia Deng; Jason B Muhitch; Gary J Smith; Kenneth W Gross; Bo Xu; Eric C Kauffman
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

7.  Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples.

Authors:  Irene Shyu; Leili Mirsadraei; Xiaoyan Wang; Valentina Robila; Rohit Mehra; Jonathan B McHugh; Ying-Bei Chen; Aaron M Udager; Anthony J Gill; Liang Cheng; Mahul B Amin; Oscar Lin; Steven Christopher Smith
Journal:  Cancer Cytopathol       Date:  2018-10-19       Impact factor: 4.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.